Source: Scandinavian Journal of Rheumatology. Unidade: FM
Subjects: DOENÇAS REUMÁTICAS (IMUNOLOGIA), INFLUENZA (IMUNOLOGIA), VACINAS VIRAIS, VACINAÇÃO, ARTRITE REUMATOIDE JUVENIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, N. E. et al. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scandinavian Journal of Rheumatology, v. 42, n. 1, p. 34-40, 2013Tradução . . Disponível em: http://informahealthcare.com/doi/abs/10.3109/03009742.2012.709272. Acesso em: 01 nov. 2024.APA
Aikawa, N. E., Campos, L. M. A., Goldenstein-Schainberg, C., Saad, C. G. S., Ribeiro, A. C., Bueno, C., et al. (2013). Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scandinavian Journal of Rheumatology, 42( 1), 34-40. doi:10.3109/03009742.2012.709272NLM
Aikawa NE, Campos LMA, Goldenstein-Schainberg C, Saad CGS, Ribeiro AC, Bueno C, Precioso AR, Timenetsky M do C, Silva CAA, Bonfá E . Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis [Internet]. Scandinavian Journal of Rheumatology. 2013 ; 42( 1): 34-40.[citado 2024 nov. 01 ] Available from: http://informahealthcare.com/doi/abs/10.3109/03009742.2012.709272Vancouver
Aikawa NE, Campos LMA, Goldenstein-Schainberg C, Saad CGS, Ribeiro AC, Bueno C, Precioso AR, Timenetsky M do C, Silva CAA, Bonfá E . Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis [Internet]. Scandinavian Journal of Rheumatology. 2013 ; 42( 1): 34-40.[citado 2024 nov. 01 ] Available from: http://informahealthcare.com/doi/abs/10.3109/03009742.2012.709272
